Oral Dosage Form New Animal Drugs; Clomipramine Hydrochloride Tablets

FederalRegulations

Ask Donna

How this section applies to your facts.

Federal Register › Vol. 64 › 64 FR 1761

This text was captured on Sep 30, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 520

Oral Dosage Form New Animal Drugs; Clomipramine Hydrochloride

Tablets

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal

drug regulations to reflect approval of a new animal drug application

(NADA) filed by Novartis Animal Health US, Inc. The NADA provides for

oral veterinary prescription use of clomipramine hydrochloride tablets

to be used as part of a comprehensive behavioral management program to

treat separation anxiety in dogs greater than 6 months of age.

EFFECTIVE DATE: January 12, 1999.

FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center for

Veterinary Medicine (HFV-110), Food and Drug Administration, 7500

Standish Pl., Rockville, MD 20855, 301-827-7540.

SUPPLEMENTARY INFORMATION: Novartis Animal Health US, Inc., P.O. Box

18300, Greensboro, NC 27419-8300, filed NADA 141-120 that provides for

oral veterinary prescription administration of ClomicalmTM

(clomipramine hydrochloride) tablets at 2 to 4 milligrams (mg)/kilogram

body weight per day (0.9 to 1.8 mg per pound per day) administered as a

single daily dose or divided twice daily to dogs greater than 6 months

of age. The NADA is approved as of December 10, 1998, and the

regulations are amended in 21 CFR

part 520 by adding new Sec. 520.455 to reflect the approval. The basis

for approval is discussed in the freedom of information summary.

In accordance with the freedom of information provisions of 21 CFR

part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness

data and information submitted to support approval of this application

may be seen in the Dockets Management Branch (HFA-305), Food and Drug

Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852,

between 9 a.m. and 4 p.m., Monday through Friday.

Under section 512(c)(2)(F)(i) of the Federal Food, Drug, and

Cosmetic Act (21 U.S.C. 360b(c)(2)(F)(i)), this approval qualifies for

a 5-year period of marketing exclusivity beginning December 10, 1998,

because no active ingredient (including any ester or salt of the active

ingredient) has been approved in any other application.

FDA has determined under 21 CFR 25.33(d)(1) that this action is of

a type that does not individually or cumulatively have a significant

effect on the human environment. Therefore, neither an environmental

assessment nor an environmental impact statement is required.

List of Subjects in 21 CFR Part 520

Animal drugs.

Therefore, under the Federal Food, Drug, and Cosmetic Act and under

authority delegated to the Commissioner of Food and Drugs and

redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is

amended as follows:

PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS

1. The authority citation for 21 CFR part 520 continues to read as

follows:

Authority: 21 U.S.C. 360b.

2. Section 520.455 is added to read as follows:

Sec. 520.455 Clomipramine hydrochloride tablets.

(a) Specifications. Each tablet contains 20, 40, or 80 milligrams

of clomipramine hydrochloride.

(b) Sponsor. See No. 058198 in Sec. 510.600(c) of this chapter.

(c) Conditions of use--(1) Amount. 2 to 4 milligrams of

clomipramine hydrochloride per kilogram (0.9 to 1.8 milligrams per

pound) of body weight per day, administered as a single daily dose or

divided twice daily.

(2) Indications for use. For use as part of a comprehensive

behavioral management program to treat separation anxiety in dogs

greater than 6 months of age.

(3) Limitations. Federal law restricts this drug to use by or on

the order of a licensed veterinarian.

Dated: January 4, 1999.

Stephen F. Sundlof,

Director, Center for Veterinary Medicine.

[FR Doc. 99-639 Filed 1-11-99; 8:45 am]

BILLING CODE 4160-01-F

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.

Oral Dosage Form New Animal Drugs; Clomipramine Hydrochloride Tablets · 64 FR 1761 | Frix